ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

ASCO, AACR Nursing Society Programs Set

May 6, 1977

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month

August 14, 1992